Which patients with non-ischaemic cardiomyopathy should receive a defibrillator?

被引:0
作者
Straw, Sam [1 ,2 ,5 ]
Flett, Andrew [3 ,4 ]
Witte, Klaus K. [1 ]
机构
[1] Univ Leeds, Leeds, England
[2] Bradford Teaching Hosp Fdn Trust, Bradford, England
[3] Univ Southampton, Southampton, England
[4] Univ Hosp Southampton, Southampton, England
[5] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Clarendon Way, Leeds LS2 3AA, England
关键词
CHRONIC HEART-FAILURE; PULMONARY CONGESTION; PROGNOSTIC VALUE; LUNG ULTRASOUND;
D O I
10.1002/ejhf.3299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1432 / 1434
页数:3
相关论文
共 16 条
  • [1] 2023 ESC Guidelines for the management of cardiomyopathies Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)
    Arbelo, Elena
    Protonotarios, Alexandros
    Gimeno, Juan R.
    Arbustini, Eloisa
    Barriales-Villa, Roberto
    Basso, Cristina
    Bezzina, Connie R.
    Biagini, Elena
    Blom, Nico A.
    de Boer, Rudolf A.
    De Winter, Tim
    Elliott, Perry M.
    Flather, Marcus
    Garcia-Pavia, Pablo
    Haugaa, Kristina H.
    Ingles, Jodie
    Jurcut, Ruxandra Oana
    Klaassen, Sabine
    Limongelli, Giuseppe
    Loeys, Bart
    Mogensen, Jens
    Olivotto, Iacopo
    Pantazis, Antonis
    Sharma, Sanjay
    Van Tintelen, J. Peter
    Ware, James S.
    Kaski, Juan Pablo
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (37) : 3503 - 3626
  • [2] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Bardy, GH
    Lee, KL
    Mark, DB
    Poole, JE
    Packer, DL
    Boineau, R
    Domanski, M
    Troutman, C
    Anderson, J
    Johnson, G
    McNulty, SE
    Clapp-Channing, N
    Davidson-Ray, LD
    Fraulo, ES
    Fishbein, DP
    Luceri, RM
    Ip, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 225 - 237
  • [3] Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II
    Blacher, Mariana
    Zimerman, Andre
    Engster, Pedro H. B.
    Grespan, Eduardo
    Polanczyk, Carisi A.
    Rover, Marciane M.
    Neto, Jose A. de Figueiredo
    Danzmann, Luiz C.
    Bertoldi, Eduardo G.
    Simoes, Marcus Vinicius
    Beck-da-Silva, Luis
    Biolo, Andreia
    Rohde, Luis E.
    [J]. HEART, 2021, 107 (18) : 1487 - 1492
  • [4] Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
    Desai, Akshay S.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Vaduganathan, Muthiah
    Miao, Zi Michael
    Kondo, Toru
    Barkoudah, Ebrahim
    Brahimi, Abdel
    Connolly, Eugene
    Finn, Peter
    Lang, Ninian N.
    Mc Causland, Finnian R.
    McGrath, Martina
    Petrie, Mark C.
    McMurray, John J., V
    Solomon, Scott D.
    [J]. JAMA CARDIOLOGY, 2022, 7 (12) : 1227 - 1234
  • [5] Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI
    Elming, Marie Bayer
    Hammer-Hansen, Sophia
    Voges, Inga
    Nyktari, Eva
    Raja, Anna Axelsson
    Svendsen, Jesper Hastrup
    Pehrson, Steen
    Signorovitch, James
    Kober, Lars
    Prasad, Sanjay K.
    Thune, Jens Jakob
    [J]. AMERICAN HEART JOURNAL, 2020, 221 : 165 - 176
  • [6] Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure)
    Flett, Andrew
    Cebula, Anna
    Nicholas, Zoe
    Adam, Robert
    Ewings, Sean
    Prasad, Sanjay
    Cleland, John G. F.
    Eminton, Zina
    Curzen, Nicholas
    [J]. AMERICAN HEART JOURNAL, 2023, 266 : 149 - 158
  • [7] Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey
    Haugaa, Kristina H.
    Tilz, Roland
    Boveda, Serge
    Dobreanu, Dan
    Sciaraffia, Elena
    Mansourati, Jacques
    Papiashvili, Giorgi
    Dagres, Nikolaos
    [J]. EUROPACE, 2017, 19 (04): : 660 - 664
  • [8] Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
    Kadish, A
    Dyer, A
    Daubert, JP
    Quigg, R
    Estes, NAM
    Anderson, KP
    Calkins, H
    Hoch, D
    Goldberger, J
    Shalaby, A
    Sanders, WE
    Schaechter, A
    Levine, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2151 - 2158
  • [9] New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial
    Karacan, Munise N.
    Doi, Seiko N.
    Yafasova, Adelina
    Thune, Jens Jakob
    Nielsen, Jens C.
    Haarbo, Jens
    Bruun, Niels E.
    Gustafsson, Finn
    Eiskjaer, Hans
    Hassager, Christian
    Svendsen, Jesper H.
    Hofsten, Dan E.
    Pehrson, Steen
    Kober, Lars
    Butt, Jawad H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (06) : 1423 - 1431
  • [10] Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients With Nonischemic Cardiomyopathy
    Klem, Igor
    Klein, Michael
    Khan, Mohammad
    Yang, Eric Y.
    Nabi, Faisal
    Ivanov, Alexander
    Bhatti, Lubna
    Hayes, Brenda
    Graviss, Edward A.
    Nguyen, Duc T.
    Judd, Robert M.
    Kim, Raymond J.
    Heitner, John F.
    Shah, Dipan J.
    [J]. CIRCULATION, 2021, 143 (14) : 1343 - 1358